Skip to content

Divide and Conquer With Debulking in Management of Rocky Hard Cataract

Divide and Conquer With Debulking in Management of Rocky Hard Cataract

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07654387
Enrollment
50
Registered
2026-06-17
Start date
2026-07-01
Completion date
2026-11-01
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Mature

Brief summary

The management of nucleus may be challenging in rocky hard cataracts. Hard cataracts are difficult to fragment, and the excessive energy required to emulsify the hard nucleus can result in complications such as corneal edema, inflammation, wound burn, posterior capsular rupture, and zonular dialysis. different surgical techniques are used for the management of hard cataracts, with their advantages and limitations. Divide and conquer with debulking is a new technique for management of rocky hard cataract. In this research we assess its safety comparing it with standard divide and conquer technique.

Detailed description

The management of nucleus may be challenging in rocky hard cataracts. Hard cataracts are difficult to fragment, and the excessive energy required to emulsify the hard nucleus can result in complications such as corneal edema, inflammation, wound burn, posterior capsular rupture, and zonular dialysis. different surgical techniques are used for the management of hard cataracts, with their advantages and limitations. Divide and conquer with debulking is a new technique for management of rocky hard cataract. In this research we assess its safety comparing it with standard divide and conquer technique.

Interventions

PROCEDUREcataract operation by phacoemulsification

phacoemulsification either by standard divide and conquer or divide and conquer with debulking.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* adults with rocky hard cataract

Exclusion criteria

* patients with abnormal endothelial cell count. * patients with glaucoma. * patients with retinal problems.

Design outcomes

Primary

MeasureTime frame
endothelial cell count3 months

Contacts

CONTACTHany Mahmoud
drhanymahmoud@gmail.com01024368111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026